Dennis Charney
When Dr. Dennis Charney, now dean of the Icahn School of Medicine at Mount Sinai, began researching the phenomenon of resilience, he could not have predicted the work would end up generating a breakthrough treatment for depression. Charney studied prisoners of war to better understand how the human mind copes with mental and physical trauma and found a common theme key to their survival: the prisoners described focusing on a mental task to distract themselves from their difficult reality. Some built a dream house in their head, while others mentally penned their future memoir. Still others practiced multiplying 12 numbers at a time.
It took nearly 20 years of further research for Charney and his mentee at the time, Brian Iacoviello, to turn that observation into the first digital treatment for major depressive disorder, called Rejoyn. Further developed by the pharmaceutical company Otsuka, the app was cleared by the U.S. Food and Drug Administration (FDA) in 2024. People with depression practice a series of exercises that rebalance the cognitive and emotional functions of the brain—which, in depression, tend to skew toward negative emotional states like rumination. Users do the memory- and emotion-based exercises three to six times a week for six weeks, practicing their recall of faces expressing various emotional states. Interpreting human emotions while flexing memory muscles helps redirect the brain away from the circuits typical of depression. Brain imaging studies of people who used Rejoyn confirmed that their brains had changed, to more closely resemble the brains of people without depression. 'We showed, to my surprise, that their depression got better,' Charney says. Researchers are now studying whether the app can help those with other conditions such as PTSD.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Cohen Veterans Network Unveils New Awareness Campaign, 'PTSD: What Therapists Want You to Know'
'Why can two people respond differently to the same trauma?' New video series answers common questions with insights from mental health experts who specialize in treating PTSD STAMFORD, Conn., June 11, 2025 /PRNewswire/ -- This June, coinciding with PTSD Awareness Month, Cohen Veterans Network (CVN), a national not-for-profit network of mental health clinics for post-9/11 veterans, service members, and their families, is launching a new public awareness campaign, "PTSD: What Therapists Want You to Know." The initiative features a video series with key insights from mental health experts who specialize in treating trauma and PTSD. The campaign aims to challenge misconceptions about the disorder and underscore that effective treatments are available. Posttraumatic Stress Disorder (PTSD) is a mental health disorder that some people develop after experiencing or witnessing a life-threatening event, like combat, a natural disaster, a car accident, or sexual assault. The U.S. Department of Veterans Affairs reports that at some point in their life, seven out of every 100 veterans (7%) will have PTSD. This rate is similar to that of the U.S. population in which six of every 100 adults (6%) will have PTSD in their lifetime. Currently, there are about 12 million people in the U.S. with PTSD. "PTSD is often misunderstood, leading to stigma and misinformation that can prevent people from seeking help," said Dr. Anthony Hassan, president and CEO of Cohen Veterans Network. "By increasing awareness and understanding about the disorder, we hope to empower more individuals to take that first step toward care. PTSD is treatable, recovery is possible, and support is available." The campaign features a series of short, informative videos with information and advice from therapists who work with PTSD every day. The videos address common questions and misconceptions, exploring topics such as why two people can respond differently to the same trauma, what causes PTSD, how to make the most out of trauma treatment, and the importance of using the term "PTSD" accurately. The campaign additionally features an article on Explaining PTSD to Kids: Four Steps for Parents, which provides strategies to help caregivers talk with children about PTSD in the home. Since 2016, CVN has cared for over 85,000 clients and provided more than 770,000 clinical sessions. Approximately 21% of the network's veteran and active duty clients have received treatment for PTSD. The network additionally treats a wide variety of mental health concerns including depression, anxiety, military transition challenges, adjustment issues, anger, grief and loss, family issues, relationship challenges, and children's behavioral problems. Care is available through the network's 22 Cohen Clinics serving 20 states in-person and via CVN Telehealth, face-to-face video therapy. For more information on "PTSD What Therapists Want You to Know" or to access the campaign video series and resources, visit Cohen Clinic b-roll is available here. ABOUT COHEN VETERANS NETWORK Cohen Veterans Network (CVN) is a 501(c)(3) national not-for-profit philanthropic organization for post- 9/11 veterans, active duty service members and their families. CVN focuses on improving mental health outcomes, operating a network of outpatient mental health clinics in high-need communities, in which trained clinicians deliver holistic evidence-based care to treat mental health conditions. It was established in 2016 by philanthropist Steven A. Cohen with a commitment of $275 million to build the network. Learn more about CVN at View original content to download multimedia: SOURCE Cohen Veterans Network
Medscape
2 days ago
- Medscape
Bipolar Depression: Choosing the Right Antipsychotic
Major depressive episodes are difficult to treat in patients with bipolar disorder I (BD-I) using traditional antidepressants. However, atypical antipsychotics can be effective in BD-I, and five FDA-approved monotherapies are discussed by Dr Joseph Goldberg, of Icahn School of Medicine at Mount Sinai, New York, NY. Dr Goldberg reports that traditional antidepressants are not overly effective in the treatment of depression in BD-I, and their use can risk destabilizing mood or exacerbating mixed features. In contrast, atypical antipsychotics have demonstrated efficacy as monotherapy for BD-I. Dr Goldberg reviews the five FDA-approved atypical antipsychotics for patients with BD-I. He then discusses the specific indications for each therapy and notes their effectiveness in treating particular comorbid features of BD-I. For example, he cites quetiapine as effective in treating anxiety, and cariprazine as beneficial for impulse control. He notes that antipsychotics, as a class, are associated with increased risk for metabolic changes, including abnormal movement disorders. However, individual agents differ in tolerability and side-effect profiles. In choosing the most appropriate agent for a given patient, Dr Goldberg advises clinicians to target the symptoms needing control, understand the therapeutic goals important to the patient, and identify the agent that has the greatest potential to meet those endpoints with the lowest risk for side effects.
Gizmodo
3 days ago
- Gizmodo
The Upsetting Truth About What Wildfire Smoke Does to Your Body
Much of Canada is ablaze again, with more than 200 active wildfires having consumed roughly 10,000 square miles (26,000 square kilometers) since January, the Canadian Interagency Forest Fire Centre reported Thursday, June 5. This escalating situation pumped massive amounts of smoke across the Canada-U.S. border, affecting air quality as far south as Florida, according to the National Oceanic and Atmospheric Administration (NOAA). As climate change lengthens and intensifies wildfire season in many regions across the world, understanding the dangers of smoke exposure is increasingly important. A wave of new research paints a complex picture of how wildfire smoke impacts the body, linking it to startling health outcomes that go far beyond the respiratory system. 'There is an urgent need for research to fully understand the health impacts of wildfire smoke to raise awareness among public and health professionals, as well as to support the development of effective regulations to mitigate the impacts,' Yaguang Wei, assistant professor of environmental medicine at Mount Sinai's Icahn School of Medicine, recently told the Harvard Gazette. Wei is the lead author of a new study, published in May in the journal Epidemiology, which found that wildfire smoke can damage the lungs and heart for up to three months after the fire is out. He and his colleagues linked this 'medium-term' exposure to increased risks of various cardiorespiratory conditions, including heart disease, stroke, high blood pressure, pneumonia, chronic lung disease, and asthma. 'Even brief exposures from smaller fires that last only a few days can lead to long-lasting health effects,' Wei told the Harvard Gazette. Infectious fumes Wildfire smoke is a mixture of gases, air pollutants, water vapor, and fine particulate matter (PM2.5), according to the Environmental Protection Agency (EPA). It contains significant levels of toxic compounds such as polycyclic aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs), some of which are known carcinogens. Recent studies even suggest that wildfire smoke carries microbial and fungal pathogens. One such study, published in the ISME Journal in 2021, noted that 80% of microbes found in wildfire smoke samples were still viable. While it's still unclear how these organisms survive the extremely high temperatures in wildfires, researchers do have an idea of how they get into the smoke in the first place. George Thompson, a professor of medicine at the University of California, Davis, who was not involved in the study, told Gizmodo that wildfires pull pathogens from the surrounding soil and vegetation as they draw in air. 'The good news is, most of those bacteria and fungi really don't cause infections [in healthy individuals],' Thompson said. 'We're most concerned for our patients whose immune systems have been impacted already,' such as those receiving chemotherapy or recovering from trauma, he added. A 2023 study, however, found evidence to suggest that wildfire smoke could raise infection risk among the general population. The findings, published in The Lancet, Planetary Health, associated California wildfires with an 18% to 22% increase in invasive fungal infections such as valley fever. Thompson pointed out that the study was based on large hospital data, which is 'a great start,' but further research will need to corroborate this link. The brain on fire The most hazardous component of wildfire smoke is not pathogens, but PM2.5. These minuscule particles penetrate deep inside the lungs and wreak havoc on the respiratory system. Previous research has shown that the tiniest, ultrafine particles can pass from the lungs directly into the bloodstream. This can damage blood vessels and trigger harmful inflammation and oxidative stress in various organs, including the brain. Multiple studies have associated wildfire smoke exposure with incidence of dementia. Last year, research published in JAMA Neurology analyzed health data from more than 1.2 million Southern Californians aged 60 and older, and found a significant link between long-term exposure to wildfire-related PM2.5 and a heightened risk of dementia. Specifically, every 1 microgram per cubic meter increase in the three-year average of wildfire PM2.5 raised the odds of a dementia diagnosis by 18%. In comparison, the same increase in PM2.5 from non-wildfire sources was linked to only a 1% greater risk of developing dementia. 'I was expecting for us to see an association between wildfire smoke exposure and dementia,' lead author Holly Elser, an epidemiologist and resident physician in neurology at the University of Pennsylvania, told the Los Angeles Times in 2024. 'But the fact we see so much stronger of an association for wildfire as compared to non-wildfire smoke exposure was kind of surprising.' Psychological fallout Other studies have linked wildfire smoke to adverse psychological outcomes. Research published in JAMA Network Open in April analyzed data on wildfire PM2.5 levels and mental health-related emergency department visits throughout California between July and December 2022—the state's worst wildfire season on record. The study found that wildfire smoke correlated with a significant spike in mental health emergency department visits for up to seven days post-exposure. 'Our study suggests that—in addition to the trauma a wildfire can induce—smoke itself may play a direct role in worsening mental health conditions like depression, anxiety, and mood disorders,' co-author Kari Nadeau, a physician-scientist at the Harvard T.H. Chan School of Public Health, said in a university statement. Questions remain All of this research demonstrates that wildfire smoke is more than just a respiratory hazard. But experts are still in the early stages of unraveling its complex health impacts—particularly in terms of mental health, Angela Yao, a senior scientist with the Environmental Health Services at the B.C. Centre for Disease Control in Canada, told Gizmodo. Many questions remain unanswered, she said. For example, 'How do you disentangle the impact of smoke from the impact of the fire itself?' Future studies will need to investigate these confounding factors. But, 'even with the current evidence that we have—it already gives us confidence that we should take a lot of action,' she added. To protect yourself from the hazards of wildfire smoke, Yao recommended limiting the length and intensity of time spent outdoors. 'The harder you breathe, the more smoke you inhale,' she said. If you must go outside, wearing an N95 mask or a P100 can reduce your smoke exposure, according to the EPA. Keep windows and doors shut to ensure that your indoor air is safe. It's also important to make sure your home's HVAC system is running properly, Yao added. If you don't have one, you can purchase a portable air filter or build your own using a furnace filter and a box fan. As wildfire season becomes increasingly impactful, taking steps to protect yourself and your family from smoke has never been more critical. Experts still have a long way to go towards fully understanding the risks of wildfire exposure, but one thing is clear—these hazards aren't going away any time soon.
